September 19, 2014 8:03 PM ET

Biotechnology

Company Overview of Arrow Therapeutics, Ltd.

Company Overview

As of February 28, 2007, Arrow Therapeutics, Ltd. was acquired by AstraZeneca PLC. Arrow Therapeutics, Ltd., a biotechnology company, focuses on the discovery and development of anti-viral therapies. It provides RSV604, a small molecule antiviral therapy for respiratory syncytial virus; and AZD2836 and AZD7295 that are compounds used in the treatment of Hepatitis C virus infection. The company was founded in 1998 and is headquartered in London, the United Kingdom.

Britannia House

7 Trinity Street

London,  SE1 1DB

United Kingdom

Founded in 1998

Phone:

44 20 7015 1000

Fax:

44 20 7015 1020

Key Executives for Arrow Therapeutics, Ltd.

Arrow Therapeutics, Ltd. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Crusade Laboratories Ltd. Europe
Aquapharm Biodiscovery Limited Europe
FuturaGene Plc Europe
Abcodia Ltd. Europe
Synthace Ltd Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arrow Therapeutics, Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.